Evidence map›Paper›PMID 32311776›Full record

ReviewCA: a cancer journal for clinicians2020

Innovations in research and clinical care using patient-generated health data.

Heather S L Jim, Aasha I Hoogland, Naomi C Brownstein, Anna Barata, Adam P Dicker, Hans Knoop, Brian D Gonzalez, Randa Perkins, Dana Rollison, Scott M Gilbert and 4 more

Abstract readReview
In one paragraph

Review in CA: a cancer journal for clinicians, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. A Systematic Review on Visualizations for Self-Generated Health Data for Daily Activities.International journal of environmental research and public health · 2022
    Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Exploring approaches to computational representation and classification of user-generated meal logs.Journal of the American Medical Informatics Association : JAMIA · 2026
    Article
  11. Article
  12. Observational
  13. Observational
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Heather S L JimDepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida.ORCID 0000-0001-7353-3711
Aasha I HooglandDepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida.
Naomi C BrownsteinDepartment of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida.ORCID 0000-0002-9991-427X
Anna BarataDepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida.
Adam P DickerDepartment of Radiation Oncology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.
Hans KnoopDepartment of Medical Psychology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, the Netherlands.
Brian D GonzalezDepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida.ORCID 0000-0001-5108-5735
Randa PerkinsDepartment of Clinical Informatics and Clinical Systems, Moffitt Cancer Center, Tampa, Florida.
Dana RollisonDepartment of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida.
Scott M GilbertDepartment of Genitourinary Oncology, Moffitt Cancer Center, Tampa, Florida.
Ronica NandaDepartment of Radiation Oncology, Moffitt Cancer Center, Tampa, Florida.
Anders BerglundDepartment of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida.ORCID 0000-0002-0393-3530
Ross MitchellDepartment of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida.
Peter A S JohnstoneDepartment of Radiation Oncology, Moffitt Cancer Center, Tampa, Florida.

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI KENNETH Lynn WRIGHT · 1998 to 2026
$93.5M
Improving Prediction of Chemotherapy-Induced Nausea: Integrating Genes, Behavior, and the MicrobiomeR01CA219389 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI JIM, HEATHER S.L. · 2018 to 2022
$3.5M
Randomized Placebo Controlled Trial of Bupropion for Cancer Related FatigueR01CA214647 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI JIM, HEATHER S.L. · 2018 to 2022
$3.0M
Developing a Culturally Targeted mHealth Intervention for Cancer-Related Sleep Disturbance in African American Breast Cancer SurvivorsK01CA211789 · NCI · RBHS -CANCER INSTITUTE OF NEW JERSEY · PI GONZALEZ, BRIAN D · 2016 to 2019
$585k
NCI NIH HHS K01 CA211789NCI NIH HHS P30 CA076292NCI NIH HHS R01 CA214647NCI NIH HHS R01 CA219389
6 · The paper itself

Abstract

Patient-generated health data (PGHD), or health-related data gathered from patients to help address a health concern, are used increasingly in oncology to make regulatory decisions and evaluate quality of care. PGHD include self-reported health and treatment histories, patient-reported outcomes (PROs), and biometric sensor data. Advances in wireless technology, smartphones, and the Internet of Things have facilitated new ways to collect PGHD during clinic visits and in daily life. The goal of the current review was to provide an overview of the current clinical, regulatory, technological, and analytic landscape as it relates to PGHD in oncology research and care. The review begins with a rationale for PGHD as described by the US Food and Drug Administration, the Institute of Medicine, and other regulatory and scientific organizations. The evidence base for clinic-based and remote symptom monitoring using PGHD is described, with an emphasis on PROs. An overview is presented of current approaches to digital phenotyping or device-based, real-time assessment of biometric, behavioral, self-report, and performance data. Analytic opportunities regarding PGHD are envisioned in the context of big data and artificial intelligence in medicine. Finally, challenges and solutions for the integration of PGHD into clinical care are presented. The challenges include electronic medical record integration of PROs and biometric data, analysis of large and complex biometric data sets, and potential clinic workflow redesign. In addition, there is currently more limited evidence for the use of biometric data relative to PROs. Despite these challenges, the potential benefits of PGHD make them increasingly likely to be integrated into oncology research and clinical care.

Indexed as

Artificial IntelligenceBiomedical ResearchDelivery of Health CareHumansMedical OncologyMorbidityNeoplasmsUnited Statesneoplasmspatient-generated health dataquality of lifetelemedicine

Identifiers

PMID32311776
PMCPMC7488179

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.